Page last updated: 2024-08-23

pefloxacin and Liver Diseases

pefloxacin has been researched along with Liver Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khlebnikov, EP; Kubyshkin, VA; Terekhova, RP; Vishnevskiĭ, VA1
Bressolle, F; Galtier, M; Gonçalves, F; Gouby, A1
Csiba, A; Ludwig, E; Székely, E1
Bressolle, F; de la Coussaye, JE; Dubois, A; Eledjam, JJ; Galtier, M; Gény, F; Gomeni, R; Joubert, P; Raffanel, C; Saissi, G1
Bruno, R; Frydman, A; Gaillot, J; Iliadis, A; Le Roux, Y; Montay, G; Rosier, P1

Reviews

1 review(s) available for pefloxacin and Liver Diseases

ArticleYear
Pefloxacin clinical pharmacokinetics.
    Clinical pharmacokinetics, 1994, Volume: 27, Issue:6

    Topics: Absorption; Age Factors; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Body Fluids; Drug Interactions; Drug Resistance, Microbial; Humans; Kidney Diseases; Liver Diseases; Pefloxacin; Tissue Distribution

1994

Trials

1 trial(s) available for pefloxacin and Liver Diseases

ArticleYear
[Clinico-pharmacologic studies on pefloxacin].
    Orvosi hetilap, 1994, Mar-27, Volume: 135, Issue:13

    Topics: Administration, Oral; Aged; Aged, 80 and over; Aging; Diuresis; Drug Evaluation; Female; Humans; Kidney Failure, Chronic; Liver Diseases; Male; Middle Aged; Pefloxacin

1994

Other Studies

3 other study(ies) available for pefloxacin and Liver Diseases

ArticleYear
[Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2009, Volume: 54, Issue:3-4

    Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Echinococcosis, Hepatic; Female; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Mycoses; Pefloxacin; Postoperative Complications; Treatment Outcome

2009
Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency.
    Clinical pharmacokinetics, 1993, Volume: 25, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Tolerance; Female; Gram-Negative Bacteria; Humans; Liver Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pefloxacin

1993
Evaluation of Bayesian estimation to discriminate subpopulations of patients with altered pharmacokinetics using fragmentary data: a pilot study with pefloxacin.
    European journal of drug metabolism and pharmacokinetics, 1991, Volume: Spec No 3

    Topics: Adult; Bayes Theorem; Female; Half-Life; Humans; Kidney Diseases; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Pefloxacin; Pilot Projects; Regression Analysis

1991